26.61
0.06 (0.24%)
| Penutupan Terdahulu | 26.55 |
| Buka | 26.58 |
| Jumlah Dagangan | 350 |
| Purata Dagangan (3B) | 1,095 |
| Harga / Pendapatan (P/E TTM) | 26.58 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Aug 2025 - 15 Aug 2025 |
| Hasil Dividen (DY TTM) | 8.10% |
| Margin Keuntungan | -6.66% |
| Margin Operasi (TTM) | 37.26% |
| EPS Cair (TTM) | 1.00 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 967.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 135.24% |
| Nisbah Semasa (MRQ) | 5.54 |
| Aliran Tunai Operasi (OCF TTM) | -6.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -31.29 M |
| Pulangan Atas Aset (ROA TTM) | -6.78% |
| Pulangan Atas Ekuiti (ROE TTM) | -3.42% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | XOMA Royalty Corporation - 8.62 | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.00 |
|
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Institusi | 1.82% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Nov 2025 | Pengumuman | XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. |
| 12 Nov 2025 | Pengumuman | XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements |
| 17 Oct 2025 | Pengumuman | XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement |
| 02 Oct 2025 | Pengumuman | XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. |
| 22 Sep 2025 | Pengumuman | XOMA Royalty Declares Quarterly Preferred Stock Dividends |
| 17 Sep 2025 | Pengumuman | XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. |
| Hasil Dividen (DY TTM) | 8.10% |
| Purata Hasil Dividen 4T | 8.09% |
| Jangkaan Pembayaran Dividen Seterusnya | Jan 2026 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 03 Oct 2025 | 31 Jul 2025 | 15 Oct 2025 | 0.53906 Tunai |
| 03 Jul 2025 | 21 May 2025 | 15 Jul 2025 | 0.53906 Tunai |
| 03 Apr 2025 | 26 Feb 2025 | 15 Apr 2025 | 0.53906 Tunai |
| 03 Jan 2025 | 23 Oct 2024 | 15 Jan 2025 | 0.53906 Tunai |
| 03 Oct 2024 | 24 Jul 2024 | 15 Oct 2024 | 0.53906 Tunai |
| 03 Jul 2024 | 15 May 2024 | 15 Jul 2024 | 0.53906 Tunai |
| 02 Apr 2024 | 21 Feb 2024 | 15 Apr 2024 | 0.53906 Tunai |
| 02 Jan 2024 | 18 Oct 2023 | 16 Jan 2024 | 0.53906 Tunai |
| 04 Oct 2023 | 26 Jul 2023 | 16 Oct 2023 | 0.53906 Tunai |
| 30 Jun 2023 | 17 May 2023 | 17 Jul 2023 | 0.53906 Tunai |
| 03 Apr 2023 | 22 Feb 2023 | 17 Apr 2023 | 0.53906 Tunai |
| 03 Jan 2023 | 26 Oct 2022 | 17 Jan 2023 | 0.53906 Tunai |
| 30 Sep 2022 | 20 Jul 2022 | 17 Oct 2022 | 0.53906 Tunai |
| 30 Jun 2022 | 18 May 2022 | 15 Jul 2022 | 0.53906 Tunai |
| 31 Mar 2022 | 17 Mar 2022 | 15 Apr 2022 | 0.53906 Tunai |
| 03 Jan 2022 | 01 Dec 2021 | 17 Jan 2022 | 0.53906 Tunai |
| 30 Sep 2021 | 28 Jul 2021 | 15 Oct 2021 | 0.53906 Tunai |
| 01 Jul 2021 | 21 May 2021 | 15 Jul 2021 | 0.53906 Tunai |
| 31 Mar 2021 | 17 Mar 2021 | 15 Apr 2021 | 0.71875 Tunai |
| Papar semua | |||
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2025 | 2.16 | 4 | 8.10 |
| 2024 | 2.16 | 4 | 8.33 |
| 2023 | 2.16 | 4 | 8.49 |
| 2022 | 2.16 | 4 | 8.69 |
| 2021 | 1.80 | 3 | 6.83 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |